{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:53Z","timestamp":1790164973995,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1038\/s41386-018-0040-x","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T15:45:56Z","timestamp":1521042356000},"page":"1822-1831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8791-657X","authenticated-orcid":false,"given":"Charles P.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Nakonezny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren J.","family":"Blacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Vande Voort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4237-7776","authenticated-orcid":false,"given":"John D.","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Worrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Joon","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafiris J.","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-6503","authenticated-orcid":false,"given":"Paul E.","family":"Croarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"40_CR1","unstructured":"Centers for Disease Control and Prevention, National Center for Injury Prevention and Control (2015). Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. Accessed 23 Aug 2017. Available from: www.cdc.gov\/injury\/wisqars ."},{"key":"40_CR2","volume-title":"Preventing suicide: a global imperative","author":"World Health Organization.","year":"2014","unstructured":"World Health Organization. Preventing suicide: a global imperative. Geneva: WHO Press; 2014."},{"key":"40_CR3","first-page":"1","volume":"65","author":"L Kann","year":"2016","unstructured":"Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Hawkins J, et al. Youth risk behavior surveillance \u2013 United States, 2015. MMWR Surveill Summ. 2016;65:1\u2013174.","journal-title":"MMWR Surveill Summ"},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jaac.2017.08.015","volume":"56","author":"WE Copeland","year":"2017","unstructured":"Copeland WE, Goldston DB, Costello EJ. Adult associations of childhood suicidal thoughts and behaviors: a prospective, longitudinal analysis. J Am Acad Child Adolesc Psychiatry. 2017;56:958\u201365.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/jamapsychiatry.2017.2582","volume":"74","author":"M Olfson","year":"2017","unstructured":"Olfson M, Blanco C, Wall M, Liu SM, Saha TD, Pickering RP, et al. National trends in suicide attempts among adults in the United States. JAMA Psychiatry. 2017;74:1095\u2013103.","journal-title":"JAMA Psychiatry"},{"key":"40_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1037\/bul0000084","volume":"143","author":"JC Franklin","year":"2017","unstructured":"Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, Huang X, et al. Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research. Psychol Bull. 2017;143:187\u2013232.","journal-title":"Psychol Bull"},{"key":"40_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.165","volume":"6","author":"BP Chang","year":"2016","unstructured":"Chang BP, Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, et al. Biological risk factors for suicidal behaviors: a meta-analysis. Transl Psychiatry. 2016;6:e887.","journal-title":"Transl Psychiatry"},{"key":"40_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1176\/appi.ajp.2014.14020194","volume":"171","author":"MA Oquendo","year":"2014","unstructured":"Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME, et al. Toward a biosignature for suicide. Am J Psychiatry. 2014;171:1259\u201377.","journal-title":"Am J Psychiatry"},{"key":"40_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0781-y","volume":"19","author":"K Sudol","year":"2017","unstructured":"Sudol K, Mann JJ. Biomarkers of suicide attempt behavior: towards a biological model of risk. Curr Psychiatry Rep. 2017;19:31.","journal-title":"Curr Psychiatry Rep"},{"key":"40_CR10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/mp.2012.112","volume":"18","author":"M Sokolowski","year":"2013","unstructured":"Sokolowski M, Ben-Efraim YJ, Wasserman J, Wasserman D. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood\/adolescent physical assault. Mol Psychiatry. 2013;18:985\u201392.","journal-title":"Mol Psychiatry"},{"key":"40_CR11","doi-asserted-by":"publisher","first-page":"15653","DOI":"10.1073\/pnas.0507901102","volume":"102","author":"PV Choudary","year":"2005","unstructured":"Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA. 2005;102:15653\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"40_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/sj.mp.4002110","volume":"14","author":"TA Klempan","year":"2009","unstructured":"Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, ffrench-Mullen J, et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry. 2009;14:175\u201389.","journal-title":"Mol Psychiatry"},{"key":"40_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1523\/JNEUROSCI.4734-03.2004","volume":"24","author":"Z Merali","year":"2004","unstructured":"Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, et al. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABAA receptor subunits in frontal cortical brain region. J Neurosci. 2004;24:1478\u201385.","journal-title":"J Neurosci"},{"key":"40_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/sj.mp.4001969","volume":"12","author":"A Sequeira","year":"2007","unstructured":"Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, Benkelfat C, Rouleau GA, et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry. 2007;12:640\u201355.","journal-title":"Mol Psychiatry"},{"key":"40_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0006-8993(88)91211-5","volume":"460","author":"SC Cheetham","year":"1988","unstructured":"Cheetham SC, Crompton MR, Katona CLE, Parker SJ, Horton RW. Brain GABAA\/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Res. 1988;460:114\u201323.","journal-title":"Brain Res"},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/(SICI)1098-2396(199711)27:3<168::AID-SYN2>3.0.CO;2-B","volume":"27","author":"JT Noga","year":"1997","unstructured":"Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR, et al. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse. 1997;27:168\u201376.","journal-title":"Synapse"},{"key":"40_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2174\/18715273113129990091","volume":"12","author":"HG Bernstein","year":"2013","unstructured":"Bernstein HG, Tausch A, Wagner R, Steiner J, Seeleke P, Walter M, et al. Disruption of glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase. CNS Neurol Disord Drug Targets. 2013;12:900\u201313.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"40_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.biopsych.2008.05.028","volume":"64","author":"MO Poulter","year":"2008","unstructured":"Poulter MO, Du L, Weaver ICG, Palkovits M, Faludi G, Merali Z, et al. GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry. 2008;64:645\u201352.","journal-title":"Biol Psychiatry"},{"key":"40_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/npp.2012.248","volume":"38","author":"S Erhardt","year":"2013","unstructured":"Erhardt S, Lim CK, Linderholm KR, Janelidze S, Lindqvist D, Samuelsson M, et al. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology. 2013;38:743\u201352.","journal-title":"Neuropsychopharmacology"},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jpsychires.2008.04.004","volume":"43","author":"R Lee","year":"2009","unstructured":"Lee R, Petty F, Coccaro EF. Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J Psychiatr Res. 2009;43:353\u20139.","journal-title":"J Psychiatr Res"},{"key":"40_CR21","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.clinph.2014.08.028","volume":"126","author":"U Ziemann","year":"2015","unstructured":"Ziemann U, Reis J, Schwenkreis P, Rosanova M, Strafella A, Badawy R, et al. TMS and drugs revisited 2014. Clin Neurophysiol. 2015;126:1847\u201368.","journal-title":"Clin Neurophysiol"},{"key":"40_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jpsychires.2007.03.001","volume":"42","author":"JP Lefaucheur","year":"2008","unstructured":"Lefaucheur JP, Lucas B, Andraud F, Hogrel JY, Bellivier F, Del Cul A, et al. Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation. J Psychiatr Res. 2008;42:389\u201398.","journal-title":"J Psychiatr Res"},{"key":"40_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.biopsych.2009.09.025","volume":"67","author":"AJ Levinson","year":"2010","unstructured":"Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, Daskalakis ZJ. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry. 2010;67:458\u201364.","journal-title":"Biol Psychiatry"},{"key":"40_CR24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.clinph.2013.01.014","volume":"124","author":"N Radhu","year":"2013","unstructured":"Radhu N, de Jesus DR, Ravindran LN, Zanjani A, Fitzgerald PB, Daskalakis ZJ. A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders. Clin Neurophysiol. 2013;124:1309\u201320.","journal-title":"Clin Neurophysiol"},{"key":"40_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/2013.jamapsychiatry.24","volume":"70","author":"PE Croarkin","year":"2013","unstructured":"Croarkin PE, Nakonezny PA, Husain MM, Melton T, Buyukdura JS, Kennard BD, et al. Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder. JAMA Psychiatry. 2013;70:291\u20139.","journal-title":"JAMA Psychiatry"},{"key":"40_CR26","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","volume":"36","author":"J Kaufman","year":"1997","unstructured":"Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"40_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00004583-198403000-00011","volume":"23","author":"EO Poznanski","year":"1984","unstructured":"Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R. Preliminary studies of the reliability and validity of the Children\u2019s Depression Rating Scale. J Am Acad Child Psychiatry. 1984;23:191\u20137.","journal-title":"J Am Acad Child Psychiatry"},{"key":"40_CR28","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168:1266\u201377.","journal-title":"Am J Psychiatry"},{"key":"40_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1388-2457(00)00518-6","volume":"112","author":"JC Keel","year":"2001","unstructured":"Keel JC, Smith MJ, Wassermann EM. A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol. 2001;112:720.","journal-title":"Clin Neurophysiol"},{"key":"40_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/archpsyc.59.4.347","volume":"59","author":"ZJ Daskalakis","year":"2002","unstructured":"Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry. 2002;59:347\u201354.","journal-title":"Arch Gen Psychiatry"},{"key":"40_CR31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.clinph.2015.02.001","volume":"126","author":"PM Rossini","year":"2015","unstructured":"Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015;126:1071\u2013107.","journal-title":"Clin Neurophysiol"},{"key":"40_CR32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"40_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s002210050878","volume":"128","author":"R Chen","year":"1999","unstructured":"Chen R, Lozano AM, Ashby P. Mechanism of the silent period following transcranial magnetic stimulation: evidence from epidural recordings. Exp Brain Res. 1999;128:539\u201342.","journal-title":"Exp Brain Res"},{"key":"40_CR34","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S1388-2457(02)00264-X","volume":"113","author":"V Lazzaro Di","year":"2002","unstructured":"Di Lazzaro V, Oliviero A, Mazzone P, Pilato F, Saturno E, Insola A, et al. Direct demonstration of long latency cortico-cortical inhibition in normal subjects and in a patient with vascular parkinsonism. Clin Neurophysiol. 2002;113:1673\u20139.","journal-title":"Clin Neurophysiol"},{"key":"40_CR35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1113\/jphysiol.1993.sp019732","volume":"466","author":"M Inghilleri","year":"1993","unstructured":"Inghilleri M, Berardelli A, Cruccu G, Manfredi M. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol. 1993;466:521\u201334.","journal-title":"J Physiol"},{"key":"40_CR36","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1113\/jphysiol.1997.sp021905","volume":"498","author":"H Nakamura","year":"1997","unstructured":"Nakamura H, Kitagawa H, Kawaguchi Y, Tsuji H. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol. 1997;498:817\u201323.","journal-title":"J Physiol"},{"key":"40_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0168-5597(92)90048-G","volume":"85","author":"J Valls-Sol\u00e9","year":"1992","unstructured":"Valls-Sol\u00e9 J, Pascual-Leone A, Wassermann EM, Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol. 1992;85:355\u201364.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"40_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-7793.1999.0591t.x","volume":"517","author":"KJ Werhahn","year":"1999","unstructured":"Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol. 1999;517:591\u20137.","journal-title":"J Physiol"},{"key":"40_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00221-006-0365-2","volume":"173","author":"MN McDonnell","year":"2006","unstructured":"McDonnell MN, Orekhov Y, Ziemann U. The role of GABAB receptors in intracortical inhibition in the human motor cortex. Exp Brain Res. 2006;173:86\u201393.","journal-title":"Exp Brain Res"},{"key":"40_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2004.06.009","volume":"1028","author":"M Pierantozzi","year":"2004","unstructured":"Pierantozzi M, Marciani MG, Palmieri MG, Brusa L, Galati S, Caramia MD, et al. Effect of vigabatrin on motor responses to transcranial magnetic stimulation: an effective tool to investigate in vivo GABAergic cortical inhibition in humans. Brain Res. 2004;1028:1\u20138.","journal-title":"Brain Res"},{"key":"40_CR41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mus.20531","volume":"33","author":"B Mohammadi","year":"2006","unstructured":"Mohammadi B, Krampfl K, Petri S, Bogdanova D, Kossev A, Bufler J, et al. Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve. 2006;33:778\u201384.","journal-title":"Muscle Nerve"},{"key":"40_CR42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00221-008-1658-4","volume":"193","author":"JTH Teo","year":"2009","unstructured":"Teo JTH, Terranova C, Swayne OB, Greenwood RJ, Rothwell JC. Differing effects of intracortical circuits on plasticity. Exp Brain Res. 2009;193:555\u201363.","journal-title":"Exp Brain Res"},{"key":"40_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1152\/jn.00782.2009","volume":"103","author":"RFH Cash","year":"2010","unstructured":"Cash RFH, Ziemann U, Murray K, Thickbroom GW. Late cortical disinhibition in human motor cortex: a triple-pulse transcranial magnetic stimulation study. J Neurophysiol. 2010;103:511\u20138.","journal-title":"J Neurophysiol"},{"key":"40_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1152\/jn.00650.2010","volume":"105","author":"RFH Cash","year":"2011","unstructured":"Cash RFH, Ziemann U, Thickbroom GW. Inhibitory and disinhibitory effects on I-wave facilitation in motor cortex. J Neurophysiol. 2011;105:100\u20136.","journal-title":"J Neurophysiol"},{"key":"40_CR45","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.0.CO;2-M","volume":"21","author":"HR Siebner","year":"1998","unstructured":"Siebner HR, Dressnandt J, Auer C, Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve. 1998;21:1209\u201312.","journal-title":"Muscle Nerve"},{"key":"40_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00221-006-0790-2","volume":"179","author":"NM Benwell","year":"2007","unstructured":"Benwell NM, Mastaglia FL, Thickbroom GW. Differential changes in long-interval intracortical inhibition and silent period duration during fatiguing hand exercise. Exp Brain Res. 2007;179:255\u201362.","journal-title":"Exp Brain Res"},{"key":"40_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainres.2007.05.014","volume":"1158","author":"G Hammond","year":"2007","unstructured":"Hammond G, Vallence AM. Modulation of long-interval intracortical inhibition and the silent period by voluntary contraction. Brain Res. 2007;1158:63\u201370.","journal-title":"Brain Res"},{"key":"40_CR48","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00221-006-0402-1","volume":"173","author":"VK Kimiskidis","year":"2006","unstructured":"Kimiskidis VK, Papagiannopoulos S, Kazis DA, Sotirakoglou K, Vasiliadis G, Zara F, et al. Lorazepam-induced effects on silent period and corticomotor excitability. Exp Brain Res. 2006;173:603\u201311.","journal-title":"Exp Brain Res"},{"key":"40_CR49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0166-2236(97)01147-8","volume":"20","author":"Y Ben-Ari","year":"1997","unstructured":"Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL. GABAA, NMDA and AMPA receptors: a developmentally regulated \u02bbm\u00e9nage \u00e0 trois\u02bc. Trends Neurosci. 1997;20:523\u20139.","journal-title":"Trends Neurosci"},{"key":"40_CR50","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrneurol.2009.80","volume":"5","author":"SN Rakhade","year":"2009","unstructured":"Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol. 2009;5:380\u201391.","journal-title":"Nat Rev Neurol"},{"key":"40_CR51","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jpsychires.2009.12.007","volume":"44","author":"CE Duncan","year":"2010","unstructured":"Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, Shannon Weickert C. Prefrontal GABAA receptor \u03b1-subunit expression in normal postnatal human development and schizophrenia. J Psychiatr Res. 2010;44:673\u201381.","journal-title":"J Psychiatr Res"},{"key":"40_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ana.21167","volume":"62","author":"FS Silverstein","year":"2007","unstructured":"Silverstein FS, Jensen FE. Neonatal seizures. Ann Neurol. 2007;62:112\u201320.","journal-title":"Ann Neurol"},{"key":"40_CR53","first-page":"189","volume-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies, Third Edition: Advances in Neurology","author":"X Leinekugel","year":"1999","unstructured":"Leinekugel X, Khalilov I, McLean H, Caillard O, Gaiarsa JL, Ben-Ari Y, et al. GABA is the principal fast-acting excitatory transmitter in the neonatal brain. In: Delgado-Escueta AV, Wilson WA, Olsen RW, Porter RJ, editors. Jasper\u2019s Basic Mechanisms of the Epilepsies, Third Edition: Advances in Neurology. Vol. 79. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 189\u2013201."},{"key":"40_CR54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.1003","volume":"49","author":"DC Chugani","year":"2001","unstructured":"Chugani DC, Muzik O, Juh\u00e1sz C, Janisse JJ, Ager J, Chugani HT. Postnatal maturation of human GABAA receptors measured with positron emission tomography. Ann Neurol. 2001;49:618\u201326.","journal-title":"Ann Neurol"},{"key":"40_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jamapsychiatry.2015.3097","volume":"73","author":"Y Sun","year":"2016","unstructured":"Sun Y, Farzan F, Mulsant BH, Rajji TK, Fitzgerald PB, Barr MS, et al. Indicators for remission of suicidal ideation following magnetic seizure therapy in patients with treatment-resistant depression. JAMA Psychiatry. 2016;73:337\u201345.","journal-title":"JAMA Psychiatry"},{"key":"40_CR56","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.clinph.2013.09.011","volume":"125","author":"DR Jesus de","year":"2014","unstructured":"de Jesus DR, Favalli GP, Hoppenbrouwers SS, Barr MS, Chen R, Fitzgerald PB, et al. Determining optimal rTMS parameters through changes in cortical inhibition. Clin Neurophysiol. 2014;125:755\u201362.","journal-title":"Clin Neurophysiol"},{"key":"40_CR57","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00221-006-0472-0","volume":"174","author":"ZJ Daskalakis","year":"2006","unstructured":"Daskalakis ZJ, M\u00f6ller B, Christensen BK, Fitzgerald PB, Gunraj C, Chen R. The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res. 2006;174:403\u201312.","journal-title":"Exp Brain Res"},{"key":"40_CR58","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3389\/fnhum.2014.00669","volume":"8","author":"PE Croarkin","year":"2014","unstructured":"Croarkin PE, Nakonezny PA, Lewis CP, Zaccariello MJ, Huxsahl JE, Husain MM, et al. Developmental aspects of cortical excitability and inhibition in depressed and healthy youth: an exploratory study. Front Hum Neurosci. 2014;8:669.","journal-title":"Front Hum Neurosci"},{"key":"40_CR59","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archpsyc.1997.01830230069010","volume":"54","author":"GJ Emslie","year":"1997","unstructured":"Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54:1031\u20137.","journal-title":"Arch Gen Psychiatry"},{"key":"40_CR60","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00004583-200210000-00010","volume":"41","author":"GJ Emslie","year":"2002","unstructured":"Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2002;41:1205\u201315.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"40_CR61","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/01.chi.0000242228.75516.21","volume":"45","author":"B Kennard","year":"2006","unstructured":"Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, et al. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45:1404\u201311.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"40_CR62","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/jama.299.8.901","volume":"299","author":"D Brent","year":"2008","unstructured":"Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299:901\u201313.","journal-title":"JAMA"},{"key":"40_CR63","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/CHI.0b013e3181b5db66","volume":"48","author":"B Vitiello","year":"2009","unstructured":"Vitiello B, Brent DA, Greenhill LL, Emslie G, Wells K, Walkup JT, et al. Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study. J Am Acad Child Adolesc Psychiatry. 2009;48:997\u20131004.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"40_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-510X(00)00495-0","volume":"184","author":"P Manganotti","year":"2001","unstructured":"Manganotti P, Bortolomasi M, Zanette G, Pawelzik T, Giacopuzzi M, Fiaschi A. Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J Neurol Sci. 2001;184:27\u201332.","journal-title":"J Neurol Sci"},{"key":"40_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brs.2009.04.003","volume":"3","author":"A Minelli","year":"2010","unstructured":"Minelli A, Bortolomasi M, Scassellati C, Salvoro B, Avesani M, Manganotti P. Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients. Brain Stimul. 2010;3:15\u201321.","journal-title":"Brain Stimul"},{"key":"40_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2004.03.007","volume":"221","author":"E Robol","year":"2004","unstructured":"Robol E, Fiaschi A, Manganotti P. Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study. J Neurol Sci. 2004;221:41\u201346.","journal-title":"J Neurol Sci"},{"key":"40_CR67","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaac.2015.11.002","volume":"55","author":"M Garvey","year":"2016","unstructured":"Garvey M, Avenevoli S, Anderson K. The National Institute of Mental Health Research Domain Criteria and clinical research in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry. 2016;55:93\u201398.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"40_CR68","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","volume":"167","author":"T Insel","year":"2010","unstructured":"Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748\u201351.","journal-title":"Am J Psychiatry"},{"key":"40_CR69","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/2167702616686854","volume":"5","author":"CR Glenn","year":"2017","unstructured":"Glenn CR, Cha CB, Kleiman EM, Nock MK. Understanding suicide risk within the Research Domain Criteria (RDoC) framework: insights, challenges, and future research considerations. Clin Psychol Sci. 2017a;5:568\u201392.","journal-title":"Clin Psychol Sci"},{"key":"40_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/da.22686","volume":"35","author":"CR Glenn","year":"2017","unstructured":"Glenn CR, Kleiman EM, Cha CB, Deming CA, Franklin JC, Nock MK. Understanding suicide risk within the Research Domain Criteria (RDoC) framework: a meta-analytic review. Depress Anxiety. 2017b;35:65\u201388.","journal-title":"Depress Anxiety"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0040-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:35:31Z","timestamp":1719880531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-018-0040-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1038\/s41386-018-0040-x","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"24 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CPL receives research support from the Mayo Clinic Foundation Departmental Small Grant Program and is a site investigator for a multicenter study funded by Neuronetics, Inc. CJB receives research support from the Mayo Clinic Foundation Departmental Small Grant Program. JLVV receives equipment in-kind support from Assurex Health, Inc. for an investigator-initiated study and is a site investigator for a multicenter study funded by Neuronetics, Inc. GAW has received research support from Medtronic, Inc., Neuralynx, Inc., and Neuropace, Inc. ZJD has received research and equipment in-kind support for an investigator-initiated study from Brainsway Ltd.; he also has served on the advisory board for F. Hoffmann-La Roche Ltd. and Merck & Co., Inc. and has received speaker support from Eli Lilly and Co. PEC has received research grant support from Pfizer, Inc., NIMH (K23 MH100266), the Brain and Behavior Research Foundation, and the Mayo Clinic Foundation. He has served as a site subprincipal or principal investigator (without additional compensation) for Eli Lilly and Co., Forest Laboratories, Inc., Merck & Co., Inc., and Pfizer, Inc.; has received equipment support from Neuronetics, Inc.; and receives supplies and genotyping services from Assurex Health, Inc. for an investigator-initiated study. He is a site primary investigator for a multicenter study funded by Neuronetics, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}